by TractManager | Oct 3, 2022 | Emerging Technology Report
Relyvrio (formerly AMX0035) is an oral fixed-dose combination of sodium phenylbutyrate (PB) and taurursodiol (TURSO). PB is a prescription drug used to treat urea cycle disorders and TURSO (also known as tauroursodeoxycholic acid [TUDCA]) is a widely available...
by TractManager | Sep 29, 2022 | Emerging Technology Report
Beremagene geperpavec is an investigational topical gene therapy proposed for the treatment of open wounds in patients with dystrophic epidermolysis bullosa.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Sep 29, 2022 | Emerging Technology Report
AuroLase is a focal ablation therapy that uses gold nanoparticles and a near-infrared laser to thermally ablate localized prostate cancer.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Sep 28, 2022 | Emerging Technology Report
Tofersen is an investigational antisense oligonucleotide proposed for the treatment of amyotrophic lateral sclerosis (ALS) caused by mutations in the SOD1 gene.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Sep 27, 2022 | Emerging Technology Report
A radiolabeled monoclonal antibody targeting tumor antigen B7-H3 in development for intraventricular radioimmunotherapy for treatment of neuroblastoma central nervous system/leptomeningeal metastases.If you have a Hayes login, click here to view the full report on the...
Recent Comments